Literature DB >> 8457292

Direct growth stimulation of normal human epithelial cells by mutant p53.

F S Wyllie1, N R Lemoine, C M Barton, T Dawson, J Bond, D Wynford-Thomas.   

Abstract

We developed a high-titer amphotropic retroviral vector that expresses mutant (Ala143) human p53 to test directly the response of genetically normal human epithelial cells to p53 mutation. Contrary to our prediction, we found that in pancreatic epithelium (whose tumors display a high frequency of p53 mutation) but not in thyroid (whose tumors show an exceptionally low mutation frequency), expression of mutant p53 induced a dramatic, though self-limiting, proliferative response. This result questions the assumption that p53 mutation is relevant only to the later stages of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457292     DOI: 10.1002/mc.2940070205

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

Review 1.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

2.  Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis.

Authors:  J A Bond; M F Haughton; J M Rowson; P J Smith; V Gire; D Wynford-Thomas; F S Wyllie
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  iTRAQ-coupled 2D LC/MS-MS analysis of CXCR7-transfected papillary thyroid carcinoma cells: A new insight into CXCR7 regulation of papillary thyroid carcinoma progression and identification of potential biomarkers.

Authors:  Hengwei Zhang; Lei Yang; Zhangyi Liu; Chenxi Liu; Xuyong Teng; Lei Zhang; Bo Yin; Zhen Liu
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

4.  Oral Progenitor Cell Line-Derived Small Extracellular Vesicles as a Treatment for Preferential Wound Healing Outcome.

Authors:  Rob Knight; Emma Board-Davies; Helen Brown; Aled Clayton; Terence Davis; Ben Karatas; James Burston; Zsuzsanna Tabi; Juan M Falcon-Perez; Stephen Paisey; Phil Stephens
Journal:  Stem Cells Transl Med       Date:  2022-08-23       Impact factor: 7.655

Review 5.  Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.

Authors:  Mark C Bagley; Terence Davis; Paola G S Murziani; Caroline S Widdowson; David Kipling
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-04

6.  Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.

Authors:  Agnieszka Anna Czajka; Anna Wójcicka; Anna Kubiak; Marta Kotlarek; Elwira Bakuła-Zalewska; Łukasz Koperski; Wiesław Wiechno; Krystian Jażdżewski
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

7.  Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression.

Authors:  C M Barton; N R Lemoine
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.